Improved osseointegration and periprosthetic bone volume around cementless metal implants under bisphosphonate treatment;Verbesserung von osteointegration und periprothetischem knochenanteil zementfreier metallischer implantate unter bisphosphonatgabe

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 143, Issue 6, 2005, Pages 645-651

  Eberhardt, C ^a   Raussen, W ^a   Thiemann, S ^a   Schwarz, M ^b   Bauss, F ^a   Kurth, A A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Animal model; Bisphosphonate; Cementless implants; Ibandronate; Osseointegration

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HYDROXYAPATITE; IBANDRONIC ACID; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE PROSTHESIS; BONE REGENERATION; CONTROLLED STUDY; DOSE RESPONSE; FEMUR; METAL IMPLANTATION; MORPHOMETRICS; NONHUMAN; RAT; SURVIVAL TIME;

ANIMALS; ARTHROPLASTY, REPLACEMENT, HIP; CEMENTATION; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR; JOINT INSTABILITY; ORGAN SIZE; OSSEOINTEGRATION; RATS; RATS, SPRAGUE-DAWLEY; TITANIUM; TREATMENT OUTCOME;

EID: 29944438059     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836752     Document Type: Article

References (28)

1. Lind M, Overgaard S, Ongpipattanakul B, Nguyen T, Bünger C, Soballe K. Transforming growth factor-β1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants. J Bone Joint Surg [Br] 1996; 78: 377-382
2. Riley EH, Lane JM, Urist MR, Lyons KM, Lieberman JR. Bone morphogenetic protein-2. Biology and applications. Clin Orthop 1996; 324: 39-46
3. Skripitz R, Andreassen TT, Aspenberg P. Parathyroid hormone (1-34) increases density of rat cancellous bone in a bone chamber. J Bone Joint Surg [Br] 2000; 82: 138-141
4. Meraw SJ, Reeve CM, Wollan PJ. Use of alendronate in peri-implant defect regeneration. Peridontol 1999; 70: 151-158
5. Gondolph-Zink B. Der Einfluss der Hydroxylapatitbeschichtung auf die Osseointegration belasteter und unbelasteter Implantate. Orthopäde 1998; 27: 96-104
6. Goodship AE, Lawes TJ, Green J, Eldridge JD, Kenwright J. The use of bisphosphonates to inhibit mechanically related bone loss in aseptic loosening of hip prostheses. Trans Orthop Res Soc 1998; 23: 2
7. Denissen H, Beek E van, den Bos T van, de Blieck J, Klein C, den Hooff A van. Degradable bisphosphonate-alkaline phosphatase-complexed hydroxyapatite implants in vitro. J Bone Miner Res 1997; 12: 290-297
8. Giuliani N, Pedrzzoni M, Negri G. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodule in murine and Human bone marrow cultures In vitro and promote early osteoblastogenesis in Young and Aged Mice in vivo. Bone 1998; 22: 455-461
9. Pataki A, Müller K, Green JR, Ma YF, Li QN, Jee WS. Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 1997; 249: 458-468
10. Astrand J, Aspenberg P. Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Disord 2002; 7: 19
11. Hilding M, Bäckbro B, Ryd L. Quality of life after knee arthroplasty. A randomized study of 3 designs in 42 patients compared after 4 years. Acta Orthop Scand 1997; 68: 156-160
12. Wang X, Shanbhag A, Rubash H, Agrawal C. Short-term effects of bisphosphonates on the biomechanical properties of canine bone. J Biomed Mater Res 1999; 44: 456-460
13. Hilding M, Ryd L, Toksvig-Larsen S, Aspenberg P. Clodronate prevents prosthetic migration. A randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand 2000; 71: 553-557
14. Stocks GW, Freeman MA, Evans SJ. Acetabular cup migration. Prediction of aseptic loosening. J Bone Joint Surg [Br] 1995; 77: 853-861
15. Mochida Y, Bauer T, Akisue T, Brown P. Alendronate does not inhibit early bone apposition to hydroxyapatite-coated total joint implants: a preliminary study. J Bone Joint Surg [Am] 2002; 84: 226-235
16. Astrand J, Aspenberg P. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats. Acta Orthop Scand 2002; 73: 24-30
17. Astrand J, Skripitz R, Aspenberg P. Alendronate reduces osteolysis induced by fluid pressure in a rat model. Trans Orthop Res Soc 2000; 25: 524
18. Scammell B. Alendronate prevents periprosthetic bone loss-2 year results. J Bone Min Res 1999; 14(Suppl 1): 341
19. Soininvaara TA, Jurvelin JS, Miettinen HJ, Suomalainen OT, Alhava EM, Kroger PJ. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one year, randomized, controlled trial of 19 patients. Calcif Tissue Int 2002; 71: 472-477
20. Christ RM, Hagena FW. Die periprothetische Knochendichte nach endoprothetischem Ersatz des Kniegelenkes unter dem Einfluss von Bisphosphonaten. Osteologie 1999; 8: 54
21. Rubash H, Dorr L, Jacobs J, Maloney W, Saag K, Malbecq W, Leung A. Does alendronate inhibit the progression of periprosthetic osteolysis? Trans Orthop Res Soc 2004; 29: 1492
22. Röynesdal AK, Ambjörnsen E, Stövne S, Haanäs HR. A comparative clinical study of three different endosseous implants in edentulous mandibles. Int J Oral Maxillofac Implants 1998; 13: 500-505
23. Vercaigne S, Wolke JCG, Naert I. Bone healing capacity of titanium plasma-sprayed and hydroxylapatite-coated implants. Clin Oral Impl Res 1998; 9: 261-271
24. Söballe K, Hansen ES, Brockstedt-Rassmussen H, Pedersen CM, Bünger C. Hydroxyapatite coating enhances fixation of porous coated implants. Acta Orthop Scand 1990; 61: 299-306
25. Overgaard S, Bromose U, Lind M, Bunger C, Soballe K. The influence of crystallinity of the hydroxyapatite coating on the fixation of implants. Mechanical and histomorphometric results. J Bone Joint Surg [Br] 1999; 81: 725-731
26. Buser D, Schenk RK, Steinemann S, Fiorellini JP, Fox CH, Stich H. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res 1991; 25: 889-902
27. Okamoto Y. Accumulation of technetium-99m methylene diphosphonate. Conditions affecting adsorption to hydroxyapatite. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 115-119
28. An YH. Methods of evaluation in orthopaedic animal research. In: An YH, Friedman RJ (eds). Animal models in orthopaedic research. CRC Press, Boca Raton 1999; 92-93